Degradation of furazolidone by bacteria Acinetobacter calcoaceticus T32, Pseudomonas putida SP1 and Proteus mirabilis V7

International Biodeterioration and Biodegradation

Volumn 77, Issue , 2013, Pages 45-50

  Zhang, Weiwei ^a,b   Niu, Zongliang ^a,b   Yin, Kun ^a,b,c   Liu, Feng ^d   Chen, Lingxin ^a,b  

^a YANTAI INSTITUTE OF COASTAL ZONE RESEARCH   (China)

^b YICCAS   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Bacterial strain; Cytotoxicity; Degradation; Furazolidone; Glutathione S transferase (GST)

Indexed keywords

ACINETOBACTER CALCOACETICUS; BACTERIAL CELLS; BACTERIAL STRAINS; CARCINOGENIC PROPERTIES; CONTAMINATED ENVIRONMENT; DEGRADATION EFFICIENCY; FEED ADDITIVES; FURAZOLIDONE; GENOTOXIC; GLUTATHIONE-S-TRANSFERASE; NATURAL DEGRADATION; POTENTIAL APPLICATIONS; PROTEUS MIRABILIS; PSEUDOMONAS PUTIDA; SEAWATER ENVIRONMENT;

CYTOTOXICITY; DEGRADATION; SEAWATER;

BIODEGRADATION;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIODEGRADATION; CONCENTRATION (COMPOSITION); ENZYME ACTIVITY; FRESHWATER ENVIRONMENT; GENOTOXICITY; INOCULATION; MUTAGENICITY; POLLUTION EFFECT; SEAWATER;

ACINETOBACTER CALCOACETICUS; BACTERIA (MICROORGANISMS); BOS; MIRABILIS; PROTEUS MIRABILIS; PSEUDOMONAS PUTIDA;

EID: 84871380848     PISSN: 09648305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ibiod.2012.11.006     Document Type: Article

References (32)

1. Ali B.H. Pharmocological therapeutic and toxicological properties of furazolidone. Veterinary Research Communications 1999, 23:343-360.
2. Allocati N., Federici L., Masulli M., Di Ilio C. Glutathione transferases in bacteria. FEBS Journal 2009, 276:58-75.
3. Andrew C., von Eschenbach M.D. Enhanced Aquaculture and Seafood Inspection-report to Congress 2008, Seafood Regulations & Guidance. Online at. http://www.fda.gov/Food/FoodSafety/Product-SpecificInformation/Seafood/SeafoodRegulatoryProgram/ucm150954.htm.
4. Choo P.S. Degradation of furazolidone in fresh- and seawater. Asian Fisheries Science 1998, 11:295-301.
5. DrugBank: Showing Furazolidone (DB00614). Online at http://www.drugbank.ca/drugs/DB00614.
6. Eisig J.N., Silva F.M., Rodriguez T.N., Hashimoto C.L., Barbuti R.C. A furazolidone-based quadruple therapy for Helicobacter pylori retreatment in patients with pepticulcer disease. Clinics 2005, 60:485-488.
7. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment-A review. Chemosphere 1998, 36:357-393.
8. Hu X.Z., Xu Y., Yediler A. Determinations of residual furazolidone and its metabolite, 3-Amino-2-oxazolidinone (AOZ), in fish feeds by HPLC-UV and LC-MS/MS, respectively. Journal of Agricultural and Food Chemistry 2007, 55:1144-1149.
9. Jense H.L. Carbon nutrition if some microorganisms decomposting halogen-substituted aliphatic acids. Acta Agriculturae Scandinavica 1963, 13:404-412.
10. Jiang L.J., Zhang T.Q., Yang L.Y., Xiao L., Pan J.L., Yin D.Q. The isolation and identification of furazolidone degrading bacteria F5 and optimization of its degradation condition. Freshwater Fisheries 2007, 37:36-40.
11. Jin X., Tang S.S., Chen Q., Zou J.J., Zhang T., Liu F.Y., Zhang S., Sun C.D., Xiao X.L. Furazolidone induced oxidative DNA damage via up-regulating ROS that caused cell cycle arrest in human hepatoma G2 cells. Toxicology Letters 2011, 201:205-212.
12. Karamanakos P.N. Furazolidone and serotonin syndrome: is there any association?. Clinics 2008, 63:553-554.
13. Kuhne M., Kobe A., Fries R., Ebrecht A. Detection of oxytetracycline and furazolidone in poultry by HPLC. Archivfür Lebensmittelhygiene 1992, 43:59-63.
14. Lane D., Pace B., Olsen G., Stahl D., Sogin M., Pace N. Rapid determination of 16S ribosomal sequences for phylogenetic analyses. Proceedings of the National Academy of Sciences 1985, 82:6955-6959.
15. Lin H., Zhang T.Q., Zhou G., Zhu Q.S., Li Q. A preliminary study on the nature degradation rule of furazolidone in stimulant water environment. Jiangsu Agricultural Sciences 2007, 4:239-241.
16. Lunestad B.T. Fate and effects of antibacterial agents in aquatic environment. Chemotherapy in Aaquaculture: From Theory to Reality 1991, 151-161. Office International Des Epizooties, Paris. J. Alderman, C. Michel (Eds.).
17. Lunestad, B.T., 1992. Environmental Effects of Antibacterial Agents Used in Aquaculture. PhD thesis, Department of Microbiology and Plant Physiology, University of Bergen, Norway.
18. Lunestad B.T., Samuelsen O.B., Fjelde S., Ervik A. Photostability of eight antibacterial agents in seawater. Aquaculture 1995, 134:217-225.
19. Machado R.S., Silva M.R., Viriato A. Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children. Jornal de Pediatria 2008, 84:160-165.
20. Meng J., Mangat S.S., Grudzinski I.P., Law F.C. Evidence of 14C-furazolidone metabolite binding to the hepatic DNA of trout. Drug Metabolism and Drug Interaction 1998, 14:209-219.
21. Moreira I.S., Amorim C.L., Carvalho M.F., Castro P.M.L. Co-metabolic degradation of chlorobenzene by the fluorobenzene degrading wild strain Labrys portucalensis. International Biodeterioration & Biodegradation 2012, 72:76-81.
22. O'Connor A., Gisbert J., O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2009, 14:46-51.
23. Piccolomini R., Di Ilio C., Aceto A., Allocati N., Faraone A., Cellini L., Ravagnan G., Federici G. Glutathione transferase in bacteria: subunit composition and antigenic characterization. Journal of General Microbiology 1989, 135:3119-3125.
24. Reimão J.Q., Taniwaki N.N., Tempone A.G. Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study. Parasitology Research 2010, 106:1465-1469.
25. Samuelsen O.B., Solheim E., Lunestad B.T. Fate and microbiological effects of furazolidone in a marine aquaculture sediment. Science of the Total Environment 1991, 108:275-283.
26. Syn C.K., Swarup S. A scalable protocol for the isolation of large-sized genomic DNA with in an hour from several bacteria. Analytical Biochemistry 2000, 278:86-90.
27. Vuilleumier S. Bacterial glutathione S-transferases: what are they good for?. Journal of Bacteriology 1997, 179:1431-1441.
28. World Health Organization (WHO) Critically Important Antibacterial Agents for Human Medicine: For Risk Management Strategies of Nonhuman Use 2005, Report of a WHO working group consultation, Canberra, Australia, 15-18 February, WHO, Geneva.
29. World Health Organization (WHO) Critically Important Antimicrobials for Human Medicine: Categorization for the Development of Risk Management Strategies to Contain Antimicrobial Resistance Due to Non-human Use 2007, Report of the Second WHO Expert Meeting, Copenhagen, Denmark, 29-31 May, WHO, Geneva.
30. Wu F.Z., Ou Yang L.Q. Determination of furazolidone, furacilin in aquatic product by HPLC. Chinese Journal of Health Laboratory Technology 2006, 16:812-813.
31. Zhang W.W., Hu Y.H., Wang H.L., Sun L. Identification and characterization of a virulence-associated protease from a pathogenic Pseudomonas fluorescens strain. Veterinary Microbiology 2009, 139:183-188.
32. Zhang W.W., Xu D.X., Niu Z.L., Yin K., Liu P., Chen L.X. Isolation and characterization of Pseudomonas sp. DX7 capable of degrading sulfadoxine. Biodegradation 2012, 23:431-439.